W.H. Ireland Group PLC
02 June 2003
W.H. Ireland Group plc ('WHI' or 'the Company')
Trading statement and scrip dividend election
The board of the Company announces the following trading statement and
information in relation to the ordinary share capital of the company:
Trading Statement
Since the cessation of hostilities in Iraq, the improvement in market conditions
has seen trading in our traditional broking activities return to levels we have
not seen for more than a year, and our corporate finance income will make a
significant contribution to group turnover. We have also continued to reposition
our cost base towards more income generating areas. Taking all these factors
into account, we anticipate that our results for the half year to 31st May 2003
will show a significant improvement on those for the same period last year.
Scrip Dividend
Elections to accept the scrip dividend alternative (as set out in the circular
to shareholders dated 20 March 2003) have been received from the holders of
9,497,834 shares in aggregate, representing approximately 64.26% of the existing
issued ordinary share capital. Accordingly on 30th May 2003 249,943 new shares
were issued in satisfaction of such elections, bringing the enlarged issued
ordinary share capital to 15,031,111 shares. The cost to the Company of the
dividend made in cash amounts to £26,406 in total. Application has been made to
the London Stock Exchange for admission to trading of the 249,943 new shares.
Dealings are expected to commence on Thursday 5 June 2003.
Cancellation of the Deferred Shares
At the Annual General Meeting held on 15th April 2003 shareholders approved the
terms of a contract between the Company and its wholly owned subsidiary
Readycount Limited ('Readycount') for the purchase and cancellation of the
4,526,660 deferred shares of 5p each in the Company held by Readycount.
Accordingly, on 30th May 2003 4,526,660 deferred shares were purchased by the
Company from Readycount at par and cancelled. To ensure that there is no
diminution in the capital of the Company, the cost of the shares cancelled,
being £226,333, has been transferred to a Capital Redemption Reserve.
After completion of the above, and in accordance with the resolution passed at
the Annual General Meeting, each of the 4,526,660 authorised but unissued
deferred shares of 5p each have been converted and redesignated as one ordinary
share of 5p each, having attached thereto the rights and being subject to the
restrictions specified in the Company's articles of association.
As a result of the corporate actions outlined above, the authorised share
capital of the Company is now 34,500,000 ordinary shares of which 15,031,111 are
in issue.
Laurie Beevers, Chief Executive, commented:
'We were encouraged by the take up by shareholders of the scrip dividend
alternative, and look forward to reporting improved results for the six months
to 31 May 2003'
2 June 2003
Enquiries:
Derek Ashford, Finance Director
0161 832 2174
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.